BFC Planning’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BFC Planning's RYTM Position: Q3 2026 in Review
BFC Planning held its Rhythm Pharmaceuticals (RYTM) position steady in Q3 2026 at 5 shares worth $476. The position accounts for ﹤0.01% of the portfolio, ranked #3289.
BFC Planning first reported a position in RYTM in Q3 2025 and has held it in 5 quarters since. The position peaked at $555 in Q2 2026. 239 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- BFC Planning held 5 shares of Rhythm Pharmaceuticals worth $476 as of Q3 2026.
- BFC Planning left its Rhythm Pharmaceuticals share count unchanged in Q3 2026.
- Rhythm Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3289 holding.
- BFC Planning first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- BFC Planning's Rhythm Pharmaceuticals position peaked at $555 in Q2 2026.
- 239 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.